3-rx.comCustomer Support
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics

\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>

Join our Mailing List


You are here : 3-RX.com > Home > Breast Cancer -

Elderly with breast cancer may be undertreated

Breast CancerMay 16, 06

Women in their 80s with breast cancer tend to receive less intensive treatment compared with their younger counterparts, Israeli researchers report.

“According to our data, most women diagnosed with breast cancer at or after the age of 80, lived more than 6 years after diagnosis,” senior author Dr. Haim Gutman told Reuters Health. “A majority received less than the standard local treatment.”

Less than standard treatment was associated with somewhat increased risk of recurrence, although this “did not translate into statistically significant survival disadvantage,” he added.

Gutman, of the Rabin Medical Center, Petah Tiqwa, and his colleagues evaluated 135 women who had been diagnosed with localized breast cancer at the age of 80 years or older.

Forty-four percent of the women received standard treatment, consisting of modified radical mastectomy or lumpectomy and lymph node removal, followed by radiation therapy. The remainder received less than standard local treatment, the team reports in the medical journal Cancer.

At an average of 70 months after diagnosis, 13 percent of patients had disease recurrence and 25 percent had died.

“I would argue,” Gutman concluded, “that elderly women live long enough to suffer ... recurrences, and that survival disadvantage may become apparent if a larger number of patients is analyzed. Thus, less-than-standard treatment should be offered only after careful consideration of these facts.”

SOURCE: Cancer, April 15, 2006.

Print Version
comments powered by Disqus

  Fat grafting technique improves results of breast augmentation
  UW research shows sensor technology may help improve accuracy of clinical breast exams
  Generic Breast Cancer Drugs Boost Adherence
  New models of drug-resistant breast cancer point to better treatments
  Breast tomosynthesis increases cancer detection and reduces recall rates
  2 views are better than 1 in 3-D breast screening
  Study reveals genomic similarities between breast cancer and ovarian cancers
  Moderate exercise tied to lower breast cancer risk
  Risk for some cancers rises with U.S. obesity rate
  New genomic test spares patients chemotherapy with no adverse effect on survival
  Breast Cancer In Black Women Is A Different Disease
  Combination of Everolimus and Exemestane Improves Progression-Free Survival for Women with Metastatic Breast Cancer


Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site